SGS’ Post

Continued growth and success for Science and Innovation in Lower Austria, Niederösterreich. Four research institutions from Lower Austria, including the Danube Private University Austria (DPU), have been successful in the COMET program (Competence Centers for Excellent Technologies) attracting funding in total of 35 million Euros. The COMET Programme combines scientific competence and technological know-how in niche areas, allowing companies and research partners to work closely together, enabling the direct transfer of new knowledge into market-ready products and services. In the COMET Center, research impulses lead to new innovations for products, processes and service helping to develop solutions for key issues such as climate protection, digitalisation, mobility and health. They help to strengthen Austria as a research and business location and have a great importance for the education of young scientists. Landeshauptfrau Mag. Johanna Mikl-Leitner stated: "Success is the result of hard work, creative minds and collaboration between science and business." To read more please go to: https://lnkd.in/diZijVMS #science #innovation #healthcare #medicine #highereducation #ffg #austria #NÖ #niederösterreich

Bavaria & Queensland #researchalliance launches its #grantprogram to support Collaborative Research Projects 🌏 The Bavarian Ministry of Science and the Arts, in cooperation with the Queensland Government, has established a research alliance to support research projects between researchers from Bavaria and Queensland. Markus Blume, State Minister for Research and the Arts, emphasizes the strong commitment to the Bavaria-Queensland Research Alliance and the importance of joint research that addresses #globalchallenges: "We are separated by around 15,000 kilometers, yet our strategies for securing prosperity and stability closely align.” The aim of the alliance is to foster formal cooperation between the two governments for collaborative university-level research across various disciplines, including greener fuels, energy storage, emission reduction technologies, and the wider bioeconomy. This initiative builds on existing research and industry connections between the two states.   The areas of research to be funded cover a wide range of topics, including: 🚀 Additive Manufacturing 🚀 Aerospace 🚀 Artificial Intelligence 🚀 Cleantech and Emission Reduction Technologies 🚀 Sustainable Energy 🚀 Health, Life Sciences, Biomedical Research, and Bioeconomy 🚀 Quantum Technology On April 12, 2024, the Alliance opens its first round of #funding for two different #grants. The grant program is open to all researchers from Bavarian Universities and Universities of Applied Science in collaboration with researchers from Universities in Queensland: ➡ Seed Grants of up to €10,000 over a period of 12 months will be available. The emphasis here is on supporting travel for Bavarian researchers to Queensland to facilitate the establishment of long-term collaborations. The deadline for Seed Funding applications is May 10, 2024. ➡ Development Grants of up to €80,000 for 24 months. This program focuses on practice-oriented research that supports the development of innovative research in Bavaria and Queensland. Development Grants applications must be submitted by July 10, 2024. The grant program will be coordinated by the newly established Bavaria-Australia Coordination Unit at the University of Bayreuth. More Information on the funding programs and for applications: https://lnkd.in/ddWWw46g 📸: Dr. Lisa Leeton

Considering joining our upcoming BBSRC Innovate UK ICURe Explore programme in March 2024? This is your chance to bring groundbreaking bioscience ideas beyond the lab and explore their commercial potential. With funding of up to £35k, this programme empowers teams to showcase their market findings to a panel of sector specialists, funders and investors! This exciting opportunity is open to bioscience research teams from UK universities, BBSRC-funded institutes, and approved public sector research enterprises (PSREs). Don't miss out on this opportunity for business acceleration, innovation, and research commercialisation. Apply now at: https://lnkd.in/eHX-9-Ui If you find that your project doesn’t meet the eligibility criteria for this programme, explore our BBSRC ICURe Discover programme that is also currently open for applications. Learn more at: https://lnkd.in/eyD_7_RM Funded by BBSRC and Innovate UK Delivered by The Helix Way #biosciences #innovation #commercialisation #businessAcceleration #ICURe #innovateukfunded

Denmark’s new #LifeScience Strategy: ideas from Kendall Square🔬 Kendall Square, the global hub for life science, has inspired the Danish Life Science Council's latest strategic move; in recommendation number 6, the council highlights Denmark's commitment to fostering innovation and excellence in the life science sector. This involve the intensification of academic, business, and capital interdisciplinarity, marked by the establishment of a Danish counterpart to Kendall Square. 🚀 Just last week, ICDK Boston orchestrated a roundtable that brought together influential figures in the life science ecosystem in Boston to meet the Danish ambassador to the US. Together, we explored strategic opportunities for Denmark to glean insights and best practices from Kendall Square's thriving ecosystem. Many ideas to link Boston and Denmark were discussed including: ·        Increase mobility between research, hospitals, and industry. ·        Establish more avenues to expose Danish biotech startups and researchers to the ambitious environment in Kendall Square. ·        Provide more incentives for researchers to consistently interact with startups and industry. ·        Foster a culture where failure is seen as a learning opportunity on the path to success. ·        Intensify innovation at hospitals - both internal and external innovation. ·        Establish visible career paths for innovation in clinical research, motivating researchers to start companies. These points are our take of the roundtable discussion between Uli Stilz  Kasper Lage, Lonnie Petersen, Frederik Friis-Hansen, Ulrik B. Nielsen, Aleks Engel, Jacob Petersen, Jens Bitsch Norhave PhD MBA, Casper Grove Petersen. Thank you all for participating! As we eagerly await the launch of Denmark’s new Life Science Strategy, we invite you to delve into the details of the recommendations. Read more about the exciting developments and future prospects here: https://lnkd.in/eMBd-f6X Ministry of Industry, Business and Financial Affairs Ministry of Foreign Affairs of Denmark Ministry of Higher Education and Science DANISH BIO - DANSK BIOTEK Copenhagen Science City #LifeScienceInnovation # #KendallSquare #DenmarkInUSA

SUND Innovation Day 2023 So much passion and talent together in Mærsktårnet today to celebrate health innovation, hearing from key players, movers and shakers in the health and life science sector - both private and public. And of course also the UCPH: BII Life Science Innovation Award was handed out. Below are my key take-aways from the ladies and gentlemen below. None (specifically) quoted, none (explicitly) forgotten. 👉 Commercialising life science research is super complex. 👉 Humility and humbleness is important. 👉 Talent is a gift. Exploiting that gift is really hard work. 👉 Teams are successful, individuals are not. 👉 Stay curious. 👉 You can not sell a patent. You can sell a proof-of-business. 👉 There is nothing inherently wrong in conflict of interest, as long as they are transparent. 👉 Universities and hospitals need to develop incentive structures which support academic entrepreneurs. 👉 Innovation is making products that succeed commercially. 👉 Commercialising in life science has three ingredients: Great science. Great talant. Loads of money. 👉 A systemic #talent pool is key for industrial sector success - #MediconValley has a lot, but needs more. The outlook for Medicon Valley and #DKlifescience is strong yet we can be do much more. Trine Winterø, Anna Vestergård Jacobsen, Peter Løvschall, Pernille Berg, Fil.Dr, Stephan Christgau, Anne-Marie Engel, Petrine Wellendorph, Ali Salanti, Mette M Rosenkilde, Louise Møller Jørgensen, Cecilie Ammitzbøll, Kristian Helin, Christian E. Elling, Louise Strandberg Clemmensen, The Pipeline, UCPH Faculty of Health and Medical Sciences, UCPH KU Lighthouse‎, Københavns Universitet - University of Copenhagen, BioInnovation Institute

Since the establishment, we have tried to keep an “open doors” policy in the MCB, sharing not only equipment but also expertise and passion for science. This approach has resulted in many great achievements, such as the ERC Consolidator Grant for Dr. hab. Sebastian Glatt, whose #MCBexperience we are sharing today. Why do you believe MCB stands out among other research units? The culture of MCB is based on our community – we share our infrastructure, ideas, knowledge, results and most important of all a common culture of supporting each other. Modern research is done in teams and MCB tries to support this collaborative approach. How has MCB contributed to your academic/professional journey? MCB offered me to create my first independent research group. Therefore, MCB was crucial for me to become an independent scientist and I am very grateful for this opportunity. In your view, what are MCB's most significant accomplishments over the last 10 years? I think the establishment of an independent, world-class research institute within the existing structure of a Polish University is a very significant achievement by itself. However, I think that the successful implementation of core facilities that provide services, technical expertise and access to infrastructure to researchers from MCB, UJ, Poland and the whole world is the most impressive achievement. #MałopolskaCentreOfBiotechnology #10thMCBanniversary Jagiellonian University

Our student and trainee Laura Kick is currently conducting a survey as part of her Master's thesis on the influence of defects in remanufacturing. Please help her with your participation in the survey via the link below. https://lnkd.in/dUenfx7F The survey is part of the research project EREP in which the iwb investigates how successful remanufacturing can be enabled through the usage of data-based decision-making and intelligent process planning. Further information about the project EREP can be found on the website (https://lnkd.in/dmPS8fPy). This project is funded by the Bundesministerium für Bildung und Forschung with support of the Projektträger Karlsruhe (PTKA) am Karlsruher Institut für Technologie (KIT). Many thanks to them for enabling our research. #tumünchen #tum #tumed #iwbTUM #iwb #ResearchForFuture #WissenschaftmitHerz #TGWM #EREP #circularconomy #Remanufacturing #sustainability

AU COMPANIES OUTPERFORM IN DEAL SIZES The latest BII analysis just published https://lnkd.in/etAcyqaN truly showcase the innovation performance at Danish Life Science Universities. I'm very glad to see how this report highlight that Department of Biomedicine at Aarhus University is in a league of its own when it comes to raising funding for startups 💪   It is true, that patent applications from Danish universities have been relatively plateauing since 2018 and are lower than the most innovative universities in EU. It’s also true that we must constantly work to promote a culture that values both research quality and innovative power. That is what we strive to do every day!     Just a few days ago, NMD Pharma, established by researchers from Department of Biomedicine - Aarhus University, received DKK 559 million for new treatment against neuromuscular diseases.   Proud to be a part of the strongest performing Department in Denmark when it comes to translating science and supporting DK biotech ecosystems 😀   Thomas G. Jensen Lone Ryg Olsen Anne-Mette Hvas Jens Nielsen Health Innovation Aarhus Danish Life Science Cluster Lif - Lægemiddelindustriforeningen BioInnovation Institute   Photo: BioInnovation Institute” Innovation performance at Danish universities during 2015-2022”

Martin - you have all the rigths to be proud about AU and about e.g. NMD Pharma A/S Pharma. Truly impressive. Congratulations with that. I know how it feels - having spent three of the best years of my life at Aarhus University back in the 70's of last century. However, please note that when BioInnovation Institute made their great White Paper report, they in fact had to exclude the Embark Laboratories' Deal with Novo Nordisk because it was in a leaque of its own ... 456 M Eur (indicated with an * in the footnote of your table). If the Embark deal had been included in the table, KU and CBMR Novo Nordisk Foundation Center for Basic Metabolic Research would have been outperforming even your great institute. And, ... just wait until Ousia Pharma and SOLID Therapeutics - next in line CBMR spinn outs will be cashing in with their transpformative novel drug classes benefitting patients and adressing major unmet medical needs. Deal size - as you mention - may or may not matter, but 456 M Euro (albeit being 'Biotech Euros' for the time being) are OK and does feel good.

This week at the Bio Conference in San Diego with our fabulous Southern Nevada team, we are thrilled to share the remarkable growth and opportunities within the biotech sector. Las Vegas offers more than just a vibrant environment; it's a community committed to innovation and excellence. 🔬 Strategic Investment: Las Vegas has made significant investments in developing the medical district, showcasing a dedication to nurturing a thriving biotech ecosystem. 🎓 Academic Excellence: With prestigious institutions like UNLV and Roseman University hosting established medical schools, the city provides a solid foundation for research and talent development in biotechnology. 🏭 Unique Attributes: From the rapid pace of development to industrial assets like Apex, El Dorado Valley, and the Southwest evolving into key industrial hubs, Southern Nevada offers facilities that can be retrofitted for large-scale science operations. 🌟 Research & Innovation Hub: Las Vegas is emerging as a hub for research and innovation, leveraging resources like the Lou Ruvo Center for Brain Health to drive cutting-edge advancements in biotechnology. Exciting times lie ahead as Southern Nevada continues to foster a dynamic ecosystem for biotech growth and transformation. #BioConference #Biotechnology #Innovation #LasVegasGrowth